Related Experiment Video
Updated: Aug 6, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Association between High Bleeding Risk and 2-Year Mortality in Patients with Chronic Limb-Threatening Ischemia
Naoki Yoshioka1, Takahiro Tokuda2, Akio Koyama3
1Department of Cardiology, Ogaki Municipal Hospital.
Insights
High bleeding risk (HBR) in chronic limb-threatening ischemia (CLTI) patients significantly predicts 2-year mortality. The Academic Research Consortium for HBR (ARC-HBR) score helps guide treatment decisions for better patient outcomes.
Area of Science:
- Vascular Surgery
- Cardiology
- Geriatric Medicine
Background:
- Chronic limb-threatening ischemia (CLTI) presents a significant clinical challenge with high mortality rates.
- Patients with CLTI often have a high bleeding risk (HBR), complicating treatment strategies.
- Accurate prognostication is crucial for tailoring interventions to individual patient profiles.
Purpose of the Study:
- To evaluate the prognostic impact of HBR on 2-year mortality in CLTI patients.
- To assess the utility of the Academic Research Consortium for HBR (ARC-HBR) score in predicting outcomes.
- To determine the relationship between ARC-HBR scores and major bleeding events.
Main Methods:
- A cohort of 259 CLTI patients undergoing endovascular therapy (EVT) was analyzed.
- The Academic Research Consortium for HBR (ARC-HBR) criteria were used to calculate HBR scores.
- A Classification and Regression Tree (CART) model identified a cut-off score for 2-year all-cause mortality prediction.
Main Results:
- Patients were stratified into low (0-1.0), moderate (1.5-3.0), and high (≥3.5) ARC-HBR score groups.
- All-cause mortality (39.6%) and major bleeding events increased significantly with higher ARC-HBR scores.
- High ARC-HBR scores were independently associated with increased 2-year all-cause mortality.
Conclusions:
- The ARC-HBR score effectively predicts 2-year mortality in CLTI patients treated with EVT.
- This score aids in selecting optimal revascularization strategies for CLTI patients.
- Integrating HBR assessment into clinical practice can improve patient management and outcomes.
Aim:
Patients with chronic limb-threatening ischemia (CLTI) have a high bleeding risk (HBR) and mortality rate. The 2-year life expectancy is an important factor in deciding the appropriate treatment strategy. This study aimed to assess the influence of HBR on the prognosis of patients with CLTI.
Methods:
A total of 259 patients with CLTI who underwent endovascular therapy (EVT) (mean age, 76.2 years; male, 62.9%) between January 2018 and December 2019 were evaluated. The Academic Research Consortium for HBR (ARC-HBR) criteria were applied to each patient, and the ARC-HBR scores were calculated. The cut-off score for predicting all-cause mortality within two years was derived using a survival classification and regression tree (CART) model. Causes of death and the association between ARC-HBR scores and major bleeding events within two years were also investigated.
Results:
Based on the CART model, patients were divided into three groups (low HBR score 0-1.0, 48 patients; moderate HBR score 1.5-3.0, 176 patients; and high HBR score ≥ 3.5, 35 patients). During the study period, 82 patients (39.6%) died due to cardiac (n=23) and non-cardiac causes (n=59). All-cause mortality increased significantly with increasing ARC-HBR scores. Cox multivariate analysis revealed a significant association between high ARC-HBR scores and the risk of all-cause mortality within two years. Major bleeding events increased significantly with increasing ARC-HBR scores.
Conclusions:
The ARC-HBR score could predict 2-year mortality in patients with CLTI who underwent EVT. Thus, this score can help determine the best revascularization strategy for patients with CLTI.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Peripheral Artery Disease III: Interprofessional Care

